(Q35594085)

9 August 2017

1 reference

title

Schistosomiasis vaccines. (English)

1 reference

9 August 2017

0 references

Paul Hagan

1

1 reference

9 August 2017

Osama Sharaf

series ordinal

2

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Expert Opinion on Biological Therapy

9 August 2017

published in

1 reference

9 August 2017

volume

3

1 reference

9 August 2017

issue

8

1 reference

9 August 2017

page(s)

1271-1278

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

9 August 2017

1 reference

Isotope renography and urinary schistosomiasis: a study in a Gambian community

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Schistosomiasis: from effector and regulation mechanisms in rodents to vaccine strategies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Resistance to reinfection after treatment of urinary schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Exposure, infection and immune responses to Schistosoma haematobium in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Chemotherapy-induced, age-related changes in antischistosome antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Seeking the ghost of worms past

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Functional study of a monoclonal antibody to IgE Fc receptor (Fc epsilon R2) of eosinophils, platelets, and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Eosinophils as mediators of antibody-dependent damage to schistosomula

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Praziquantel and the control of schistosomiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Vaccine strategies against schistosomiasis: from concepts to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Schistosomiasis vaccines: a devils' advocate view

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Administration of praziquantel to pregnant and lactating women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Efficacy of artesunate against Schistosoma mansoni infections in Richard Toll, Senegal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.8.1271

10.1517/14712598.3.8.1271

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference